Canadian cannabis processor and producer Adastra Holdings Ltd. (CSE: XTRX) reported its financial results for the fourth quarter and fiscal year ending Dec. 31, 2023, showing its highest sales haul yet, which was coupled with a rise in net loss. For the fiscal year, the company posted gross revenue of …
Category: Psychedelics
Tryp Therapeutics merger with Exopharm approved by shareholders
Clinical-stage psychedelic biotech, Tryp Therapeutics, Inc., has announced that its previously announced plan to merge with Exopharm Limited has received approval from Exopharm’s shareholders. The arrangement, which is expected to close on or about May 1, has satisfied all conditions precedent, with the exception of the conditional approval from the …
The Daily Hit: April 23, 2024
The Daily Hit is a recap of the top financial news stories for Tuesday, April 23, 2024. On the Site Trulieve settles former worker’s wrongful termination lawsuit The case also alleged that the cannabis company ignored safety and sexual harassment complaints. Read more here. ‘Don’t flood the market:’ Fault lines …
Hypha Labs pivots to psilocybin with new mushroom tech
Hypha Labs Inc. (OTC: DIGP), formerly known as Digipath, announced its transition from the cannabis industry to the emerging market of functional mushrooms, with a particular focus on psilocybin. The company said it has developed a patent-pending bioreactor technology that aims to streamline the production of active ingredients found in …